Glenmark Pharma’s US subsidiary has agreed to pay $15.28 million to settle antitrust litigation with Humana over allegations involving generic drug pricing and market allocation.
​Glenmark Pharma’s US subsidiary has agreed to pay $15.28 million to settle antitrust litigation with Humana over allegations involving generic drug pricing and market allocation.  by Soban News (international And National News)